EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda

Abdulwahab Sessolo iD, Emmanuel Musisi, Sylvia Kaswabuli, Josephine Zawedde, Patrick Byanyima, Wilber Sabiiti iD, Stanley Walimbwa, Joseph Ola, Ingvar Sanyu, Rejani Lalitha iD, Moses Kamya, Lucian Davis iD und 2 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0284041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Abdulwahab Sessolo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Research Collaboration, Kampala, Uganda. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Academy for Health Innovation Uganda, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stool is a potential sample for diagnosing Mycobacterium tuberculosis ( Mtb ) in patients with difficulty in expectorating. However, high mycobacterial culture contamination rates and Xpert MTB/RIF Ultra test error rates on stool samples have limited its use. OMNIgene SPUTUM (OM-S) is a sample transport reagent with characteristics of sputum decontamination while maintaining viable Mtb . We evaluated the impact of OM-S on Mtb diagnostic yield from stool using smear microscopy, Xpert MTB/RIF Ultra, and culture among presumptive TB patients.

Methods

Paired stool and expectorated sputum samples were collected from consecutive Ugandan adults undergoing diagnostic evaluation for pulmonary TB between June 2018 and June 2019. Stool was divided into 2 portions: one was homogenized in OM-S (OM-S stool) and the other in PBS (PBS stool) as control. Both sputum and processed stool were tested for Mtb using concentrated smear fluorescence microscopy (CFM), Xpert MTB/RIF Ultra (Xpert) and Mycobacteria Growth Indicator Tube (MGIT) culture. Sensitivity, specificity, and predictive values for each test were calculated against sputum MGIT culture as the reference standard.

Results

Of the 200 participants, 120 (60%) were male, 73 (37%) were HIV positive (median CD4 120 cells/uL (IQR 43–297)) and 128 (64%) had confirmed pulmonary TB by sputum MGIT culture. Seven (4%) OM-S stool Xpert samples reported errors while 47 (25%) and 103 (61%) were contaminated on OM-S stool MGIT and PBS stool MGIT, respectively. OM-S stool MGIT was able to accurately diagnose 56 of the contaminated PBS stool MGIT samples compared to only 5 of the contaminated OM-S stool MGIT samples diagnosed by PBS stool MGIT. Sensitivity (95% Confidence Interval, CI) 89% (83–94) for OM-S stool Xpert was higher compared to that of OM-S stool MGIT 60% (51–69) and PBS stool MGIT 42% (32–52). Specificity (95%CI) 91% (82–97) was also higher for OM-S stool Xpert compared to OM-S stool MGIT 64% (51–75) and PBS stool MGIT 26% (16–38).

Conclusion

Stool processed with OM-S showed potential to improve Mtb diagnostic yield and reduce rates of indeterminate results when tested on Xpert and MGIT culture. The method may thus be of value in Mtb detection among patients with difficulty to expectorate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, PulmonaryHumansMaleAdultFemaleUgandaSputumSensitivity and SpecificityMicroscopy, Fluorescence

Autor:innen und Institutionen

  • Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Department of Biochemistry and Sports Science, Makerere University, Kampala, Uganda.
  • Division of Infection and Global Health, School of Medicine, University of St. Andrews, Scotland, United Kingdom.
  • China Uganda Friendship Hospital Naguru, Kampala, Uganda.
  • Department of Internal Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States of America.

ORCID-Profile: Abdulwahab Sessolo, Wilber Sabiiti, Rejani Lalitha, Lucian Davis

Förderung

  • NHLBI NIH HHS
  • Academy for Health Innovation Uganda
  • National Heart, Lung, and Blood Institute
  • DNAgenotek Inc.
  • SPUTUM

Zitieren

APA

Sessolo, A., Musisi, E., Kaswabuli, S., Zawedde, J., Byanyima, P., Sabiiti, W., Walimbwa, S., Ola, J., Sanyu, I., Lalitha, R., Kamya, M., Davis, L., Worodria, W., & Huang, L. (2023). Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda. PLOS ONE. https://doi.org/10.1371/journal.pone.0284041

Vancouver

Sessolo A, Musisi E, Kaswabuli S, Zawedde J, Byanyima P, Sabiiti W, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda. PLOS ONE. 2023. doi:10.1371/journal.pone.0284041

BibTeX
@article{Sessolo2023,
  author = {Sessolo, Abdulwahab and Musisi, Emmanuel and Kaswabuli, Sylvia and Zawedde, Josephine and Byanyima, Patrick and Sabiiti, Wilber and Walimbwa, Stanley and Ola, Joseph and Sanyu, Ingvar and Lalitha, Rejani and Kamya, Moses and Davis, Lucian and Worodria, William and Huang, Laurence},
  title = {Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0284041}
}
Kostenlos starten →